Prelude Therapeutics (PRLD) EPS (Basic) Growth (3y) (2022 - 2026)
Prelude Therapeutics (PRLD) EPS (Basic) Growth (3y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
-27.25% |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
139.68% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
25.99% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
41.58% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
85.94% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
14.28% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Prelude Therapeutics |
314.40 Mn |
169.80 Mn |
- |
39.26% |
| Date | Value |
|---|
| Mar 31, 2026 |
39.26% |
| Dec 31, 2025 |
30.66% |
| Sep 30, 2025 |
25.55% |
| Jun 30, 2025 |
10.92% |
| Mar 31, 2025 |
12.64% |
| Dec 31, 2024 |
18.81% |
| Sep 30, 2024 |
13.31% |
| Jun 30, 2024 |
7.44% |
| Mar 31, 2024 |
3.68% |
| Dec 31, 2023 |
-26.86% |
| Sep 30, 2023 |
55.91% |
| Jun 30, 2023 |
53.87% |
| Mar 31, 2023 |
51.61% |
| Dec 31, 2022 |
52.84% |
| Sep 30, 2022 |
45.68% |
